SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBig Yellow Regulatory News (BYG)

Share Price Information for Big Yellow (BYG)

Share Price is delayed by 15 minutes
Get Live Data
862.50    27.50 (3.29%)
Bid:
856.50
Ask:
857.50
Spread: 1.00 (0.117%)
Market Cap: £1.69b
BYG Live PriceLast checked at - London Stock Exchange

Intraday Big Yellow Share Chart

Form 8.3 - Big Yellow Group Plc

23 Oct 2025 15:20

RNS Number : 6274E
Irenic Capital Management
23 October 2025
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Irenic Capital Management LP

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Big Yellow Group Plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

N/A

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

22/10/2025

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

 

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

10p ordinary

 

 

Interests

Short positions

 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

2,022,537

1.03%

 

 

(2) Cash-settled derivatives:

 

 

 

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

 

TOTAL:

2,022,537

1.03%

 

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

(GBp)

10p ordinary

Sale

200,000

1,194.0145

10p ordinary

Sale

50,000

1,178.2170

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

23rd October 2025

Contact name:

Josh Brodman

Telephone number*:

646-993-6336

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETUOSORVVURUAA
Date   Source Headline
7th Sep 20207:00 amRNSPlanning Update
4th Sep 20209:35 amRNSBlock Listing Of Shares
1st Sep 20209:20 amRNSTotal Voting Rights
5th Aug 20204:21 pmRNSDirector/PDMR Shareholding
5th Aug 202011:17 amRNSResult of AGM
4th Aug 20209:05 amRNSTotal Voting Rights
24th Jul 20201:36 pmRNSChange of venue for AGM
15th Jul 20207:00 amRNSTrading Statement
13th Jul 202011:26 amRNSNotification of Q1 Trading Update
13th Jul 20207:00 amRNSFreehold acquisition
6th Jul 20208:38 amRNSHolding(s) in Company
6th Jul 20208:36 amRNSHolding(s) in Company
2nd Jul 202012:04 pmRNSAnnual Financial Report & Notice of AGM
2nd Jul 202010:21 amRNSAnnual Financial Report & Notice of AGM
30th Jun 202012:19 pmRNSTotal Voting Rights
15th Jun 202011:41 amRNSDirector/PDMR Shareholding
9th Jun 20207:00 amRNSResults for the year ended 31 March 2020
29th May 20209:01 amRNSTotal Voting Rights
21st May 20207:00 amRNSNotice of Results
4th May 20207:00 amRNSNon-Executive Director Appointment
30th Apr 202011:41 amRNSDisclosure of rights attached to equity shares
30th Apr 202011:04 amRNSTotal Voting Rights
21st Apr 202012:23 pmRNSBlock Listing Return
21st Apr 202010:29 amRNSDirector/PDMR Shareholding
21st Apr 20207:00 amRNSResults of placing
20th Apr 20204:40 pmRNSProposed placing of new ordinary shares
16th Apr 20203:47 pmRNSHolding(s) in Company
16th Apr 20207:00 amRNSFourth Quarter Trading Update
1st Apr 20207:00 amRNSNew Aviva debt facility
31st Mar 20209:00 amRNSTotal Voting Rights
26th Mar 20207:00 amRNSCoronavirus update
28th Feb 20208:39 amRNSTotal Voting Rights
6th Feb 202010:57 amRNSTotal Voting Rights
16th Jan 20207:00 amRNSTrading Statement
14th Jan 20207:00 amRNSNotice of Results
31st Dec 20197:00 amRNSTotal Voting Rights
16th Dec 20199:50 amRNSDirector/PDMR Shareholding
29th Nov 201912:25 pmRNSTotal Voting Rights
28th Nov 20197:00 amRNSNon-Executive Director Appointment
19th Nov 20197:00 amRNSResults for the Six Months ended 30 September 2019
8th Nov 20199:00 amRNSPlanning Update
31st Oct 20199:01 amRNSTotal Voting Rights
16th Oct 20197:00 amRNSNotice of Results
11th Oct 20197:00 amRNSPlanning Update
1st Oct 20192:05 pmRNSBlock Listing Return
1st Oct 20199:35 amRNSBlock Listing Of Shares
30th Sep 20191:11 pmRNSTotal Voting Rights
9th Sep 20199:19 amRNSDirector/PDMR Shareholding
30th Aug 201910:36 amRNSTotal Voting Rights
16th Aug 201910:37 amRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.